ADA 83rd Scientific Sessions Final Program - 306

AMERICAN DIABETES ASSOCIATION
1112‑P Soluble Suppression of Tumorigenicity 2 Is Directly Correlated with Body Fat, Metabolic
Dysfunction, and Inflammation in Children and Adolescents
AMAL HASAN, SHIHAB P. KOCHUMON, IMAN D. ALBASIRI, FAHD ALMULLA, RASHEED AHMAD, Kuwait
City, Kuwait, Jabriya, Kuwait
1113‑P Alanine Aminotransferase Elevation in Youth‑Onset Type 2 Diabetes-Prevalence and Risk
Factors
SEAN E. DELACEY, SIYUAN FENG, ADESH RANGANNA, MARK FISHBEIN, MONICA E. BIANCO, Chicago, IL
1114‑P Patient‑Reported Outcomes (PROs) during a Study of Feasibility of Continuous Glucose Monitor
(CGM) Use in Publicly Insured Youth with Type 2 Diabetes (T2D)
MOLLY L. TANENBAUM, SARAH HANES, KOREY K. HOOD, DAVID M. MAAHS, SEJAL SHAH, Palo Alto, CA,
Stanford, CA
1115‑P Advanced Medical Therapy (AMT) for Youth‑Onset Type 2 Diabetes (T2D)-Early Results from
the Run‑in Phase of ST2OMP
AMY S. SHAH, MEGAN M. KELSEY, TODD M. JENKINS, LISA R. SCHAAF, STAVRA XANTHAKOS, ANDREW
T. TROUT, AMY BAUMGARTNER, ALLEN RIEGLER, NISHA KRISHNAN, ALEXANDER BAILEY, THOMAS
INGE, MICHAEL HELMRATH, KRISTEN J. NADEAU, Cincinnati, OH, Aurora, CO, Denver, CO, Chicago, IL
1116‑P Increase in the Incidence of Type 2 Diabetes in Children <11 Years during the COVID‑19
Pandemic
SABITHA SASIDHARAN PILLAI, PHINNARA HAS, LISA S. TOPOR, MEGHAN E. FREDETTE, Providence, RI
1117‑P Variability in Glycemia Measured by CGM in Children and Young Adults with Acute Recurrent or
Chronic Pancreatitis
MARIA G. PARRA VILLASMIL, MELENA BELLIN, CATHERINA PINNARO, KATIE L. ODE, Iowa City, IA,
Minneapolis, MN
PEDIATRICS-TYPE 1 DIABETES
1118‑P Accuracy of Dexcom G6 Continuous Glucose Monitor in Pediatric Diabetic Ketoacidosis
Admissions
LAUREN A. WATERMAN, LAURA PYLE, LINDSEY TOWERS, EMILY JOST, ANGELA J. KARAMI, CARI
BERGET, GREGORY P. FORLENZA, R. PAUL WADWA, ERIN C. COBRY, Aurora, CO
1119‑P Improved Glycemic Control with Less Effort during Real‑World MiniMed 780G Advanced Hybrid
Closed‑Loop (AHCL) System Use by Children with T1D
JENNIFER MCVEAN, ARCELIA ARRIETA, TONI L. CORDERO, JAVIER CASTAÑEDA, OHAD COHEN,
Northridge, CA, Maastricht, Netherlands, Tolochenaz, Switzerland
1120‑P Higher Real‑World Time in Range Demonstrated in Children Using Recommended MiniMed 780G
(AHCL) Settings
JENNIFER MCVEAN, ARCELIA ARRIETA, TONI L. CORDERO, MATIAS CASTRO, JAVIER CASTAÑEDA, OHAD
COHEN, Northridge, CA, Maastricht, Netherlands, Santiago Chile, Tolochenaz, Switzerland
1121‑P Association between Self‑Monitored Blood Glucose and Continuous Glucose Monitor in Youth
with Type 1 Diabetes and Medicaid
JANICE CHAN, JENNIFER K. YEE, TANNAZ MOIN, ESTELLE M. EVERETT, Los Angeles, CA, Torrance, CA
1122‑P Disparities in Glycemic Outcomes in High Technology-Using Youth with Type 1 Diabetes
MERYL C. NATH, JOYCELYN ATCHISON, JESSICA SCHMITT, Birmingham, AL
1123‑P Pilot Study of Early Adoption of Automated Insulin Delivery in Under‑Resourced Youth
KEVIN YEN, SONALI BELAPURKAR, JEANNIE G. HICKEY, LOREN YGLECIAS, KAVENPREET S. BAL, LOIS
LYBECK CARELLI, CRYSTAL M. LOUCEL, MAYA LODISH, JENISE C. WONG, San Francisco, CA
1124‑P Outcomes of Health‑Related Social Needs Screening in a Midwest Pediatric Diabetes Clinic
Network
KELSEE HALPIN, SHILPI RELAN, JASMINE ROGHAIR, RHIANNON POMERANTZ, KATELYN EVANS,
MITCHELL S. BARNES, HEATHER FEINGOLD, SAMANTHA N. JACOB, COURTNEY WINTERER, JEFFREY D.
COLVIN, MARK A. CLEMENTS, EMILY L. DEWIT, Kansas City, MO, Wichita, KS, Overland Park, KS
306
Clinical Diabetes/Therapeutics
POSTERS
ADA 83rd Scientific Sessions Final Program

Table of Contents for the Digital Edition of ADA 83rd Scientific Sessions Final Program
